One Technology Place  Rockland, MA 02370
As a leader in fertility health, EMD Serono, Inc. is dedicated to providing patient-friendly, innovative products that are used to treat infertility, a common condition that affects approximately 7.3 million people in the US.1 EMD Serono is the only company to offer recombinant version of three hormones used in the treatment of infertility. These include Gonal-f® (follitropin alfa for injection), Ovidrel® Prefilled Syringe (choriogonadotropin alfa injection) and Luveris® (lutropin alfa for injection). Rounding out EMD Serono, Inc.’s portfolio of fertility treatmentsis Cetrotide® (cetrorelix acetate for injection) used to control certain hormonal surges. Click on any product name above for additional product and full prescribing information. 1 Fertility, Family Planning, and Reproductive Health of U.S. Women: Data from the 2002 National Survey of Family Growth. (PHS) 2006-1977. 174 pp. Infertility Infertility is defined as the inability to achieve pregnancy after one year of regular unprotected intercourse (six months if the woman is over 35). The most recent estimates indicate infertility affects more than 7.3 million Americans, which represents 1 in 6 couples in their childbearing years. While infertility can be an emotionally uncertain and frustrating journey, it can often be successfully treated. The majority of patients who complete recommended treatment for infertility ultimately succeed in having a child.2 For more information, call toll-free 1-866-LETS-TRY (1-866-538-7879) or visit www.FertilityLifeLines.com. 2 Corson S. Conquering Infertility. Vancouver, BC:EMIS-Canada;1999, 2002 National Survey of Family Growth.